receptor interference gene therapy (EnFutech)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namereceptor interference gene therapy (EnFutech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionHIV envelope protein gp120 inhibitors
TargetsHIV envelope protein gp120
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnFutech ApS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnFutech ApS
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A